Guizhen Wu to Antibodies, Viral
This is a "connection" page, showing publications Guizhen Wu has written about Antibodies, Viral.
Connection Strength
0.111
-
Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19. JCI Insight. 2021 02 22; 6(4).
Score: 0.022
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.021
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.021
-
Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg Microbes Infect. 2016 Nov 09; 5(11):e113.
Score: 0.016
-
Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
Score: 0.006
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.005
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.005
-
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020 05 29; 368(6494):1016-1020.
Score: 0.005
-
Serological Investigation of Laboratory-Confirmed and Suspected Ebola Virus Disease Patients During the Late Phase of the Ebola Outbreak in Sierra Leone. Virol Sin. 2018 Aug; 33(4):323-334.
Score: 0.005
-
Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans. Vaccine. 2017 10 09; 35(42):5644-5652.
Score: 0.004